Yasushi Okazaki
Yasushi Okazaki is an expert in Genetics at Juntendo University (Japan). Yasushi Okazaki has authored 388 publications, the most recent in 2026. SLR score: 1,039 (community average: 125). How the SLR is computed.
LeadR Profile
Genetics
Subspecialties: Oncology - Neurology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1986 - 2026
Number : 388
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genome-wide mapping of the Galleria mellonella transcription start sites during fungal infection and treatment. PMID 42866649 — promoter regions, genetic, genome, transcription initiation site, mycoses, larva, therapeutics, enhancer elements, genetic, infections | iScience | 2026 | 0 |
| MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease. PMID 42779990 — microglia, cells, galectins, aging, stress, physiological, mitochondria, galectin 3, inflammasomes, liver, dna, mitochondrial, gaucher disease | Res Sq | 2026 | 0 |
| CD4 CTLs in supercentenarians: Signs of adaptive expansion in healthy aging. PMID 42617599 — cells, biological science disciplines, aging, neoplasms, signs and symptoms, healthy aging, clone cells | Cell Rep | 2026 | 5 |
| Non-invasive urinary heteroplasmy screening outperforms blood testing for certain mitochondrial DNA variants in mitochondrial disease patients. PMID 42424991 — research design, mitochondrial diseases, muscles, blood, metabolic diseases, molecular biology, dna, mitochondrial, heteroplasmy, muscle, skeletal, tissues | Mol Genet Metab | 2026 | 0 |
| A Lynch syndrome patient with multiple cancers who was found to have a novel pathogenic variant generating aberrant splicing of MLH1. PMID 42407056 — genes, dna mismatch repair, polymerase chain reaction, neoplasms, exons | Jpn J Clin Oncol | 2026 | 0 |
LeadR Networks
Main global connection map